New Alzheimer's treatment aims to slow memory loss
NCT ID NCT07191028
Summary
This study is testing whether a traditional Chinese medicine formulation called MLC901 (NeuroAiD™II) can slow down cognitive decline in people with mild to moderate Alzheimer's disease. About 350 participants will take either MLC901 or a placebo for 12 months to see if the treatment helps preserve memory and thinking skills better than the placebo. The study will also check for side effects and measure certain blood markers related to Alzheimer's.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER'S DISEASE DEMENTIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
National University Hospital Singapore
Singapore, Singapore
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.